Helping reduce the spread of animal-borne diseases
Without access to veterinary care and vaccines, free-roaming dogs and cats on tribal lands and in underserved communities can be vectors for diseases. Greater Good® Charities, a leading nonprofit helping animals across the world, has been at the forefront of providing animals and communities in need with essential care.
In 2022, Boehringer Ingelheim is teaming up with Greater Good Charities to support its efforts through our SHOTS FOR GOOD℠ program. SHOTS FOR GOOD is a Boehringer Ingelheim charitable initiative that helps provide vaccines and veterinary care to communities in need. Boehringer Ingelheim has agreed to donate up to 48,000 IMRAB® vaccines, 48,000 RECOMBITEK® vaccines, and 3,300 PUREVAX® vaccines to help stop the spread of distemper, panleukopenia, parvo, and rabies viruses, which put indigenous animals, wildlife, and livestock at risk. Together, we can help protect dogs and cats against preventable diseases and provide veterinary care to underserved communities.
Partnering for the Greater Good
The Shots for Good℠ program is uniquely positioned to donate vaccines to qualified organizations that provide free veterinary care on tribal lands and in underserved communities. We will focus on states with large populations of free-roaming reservation dogs, and work with the trusted organizations serving the indigenous populations. Our goal is to provide the necessary vaccines to help protect as many as 48,000 dogs and 3,300 cats from preventable disease.
Greater Good® Charities is a 501(c)(3) national nonprofit organization that works to help people, pets, and the planet by mobilizing in response to need and amplifying the good. Greater Good Charities, with a 100/100 rating on Charity Navigator, has provided more than $400 million in impact, including cash grants, in-kind supplies, and programmatic support, to over 5,000 charitable partners in 121 countries since 2007.
To learn more about how Greater Good Charities is amplifying the good across the globe, please visit greatergood.org or follow on Facebook, Instagram, Twitter, YouTube, and TikTok.
In 2019, Boehringer Ingelheim partnered with Greater Good Charities to join the fight against rabies in Puerto Rico. Over the course of this 3-year partnership, we donated doses of our US market-leading rabies vaccine brand,1 IMRAB®, and proof-of-vaccination seals to help prevent rabies in 60,000 dogs and cats.
In 2018, Boehringer Ingelheim partnered with the Global Alliance for Rabies Control (GARC) to donate 75,000 doses of rabies vaccine to be administered to dogs and cats in Madagascar, where an estimated 200 people die from rabies each year.2